Peptide PCT: When You Actually Need It

Most peptides do NOT need PCT — they do not suppress the HPTA the way anabolic steroids do. The real concern is receptor desensitization, which calls for cycling rather than post-cycle hormone restart. Here is the per-class breakdown of when to cycle, when to PCT, and when to do neither.

🔬 Peptide PCT is one of the most-confused topics in the community. People copy steroid-PCT protocols (clomid, nolvadex, hCG) onto GH secretagogue cycles where they make no biological sense. The rule is simple: PCT is for HPTA suppression. If the compound does not suppress LH/FSH/testosterone, it does not need PCT.

Typical Secretagogue
Cycle Length

Typical Off-Cycle
Resensitization

BPC-157/TB-500
PCT Requirements

Mechanism of Action

How It Works

🚫

No HPTA Suppression = No PCT

BPC-157, TB-500, GHK-Cu, MOTS-c, Selank, Semax, DSIP, oxytocin, thymosin alpha-1 — these peptides do not suppress the hypothalamic-pituitary-testicular axis. Stopping them does not cause testosterone crash. PCT (clomid, nolvadex, hCG) is unnecessary.

🔄

Receptor Desensitization → Cycle, Don't PCT

Ipamorelin, CJC-1295, sermorelin, tesamorelin, hexarelin — GH secretagogues. Pituitary GHRHR/GHSR receptors desensitize with continuous use. Solution: cycle (8-12 weeks on, 4-6 weeks off) for resensitization. Not PCT — just a planned break.

💉

AAS-Stacked Peptides → Real PCT Required

If you ran peptides alongside anabolic steroids or SARMs (LGD-4033, RAD-140), the AAS suppressed HPTA, not the peptides. PCT (clomid, nolvadex, sometimes hCG bridge) is needed for the steroid suppression. The peptides are bystanders in this PCT discussion.

⚠️

Recombinant HGH → Pituitary Suppression

Exogenous recombinant HGH provides feedback that suppresses endogenous GH production. Long-term recombinant GH users may need a tapered cessation, but this is "weaning" not "PCT" in the AAS sense. Discuss with prescribing physician.

Data

What the Data Shows

BPC-157, TB-500, GHK-Cu, MOTS-c — PCT Need

No HPTA suppression

None

Ipamorelin, CJC-1295, Sermorelin — Cycling

Receptor desensitization concern

Cycle

Selank, Semax, Oxytocin, DSIP — PCT Need

No HPTA effect

None

Recombinant HGH — Tapered Cessation

Pituitary feedback suppression

Taper

AAS-Stacked Peptide Cycles — Real PCT

Steroid PCT (clomid/nolva) is for the steroid

Yes

Bottom Line

Key Takeaways

✅ What We Know

PCT is for HPTA suppression. If the peptide does not suppress LH/FSH/testosterone, PCT is not needed
Healing peptides (BPC-157, TB-500, GHK-Cu, MOTS-c, KPV) need neither cycling nor PCT in monotherapy
GH secretagogues (ipamorelin, CJC-1295, sermorelin) need CYCLING for receptor resensitization, not PCT
Cognitive/anxiety peptides (Selank, Semax, DSIP, oxytocin) need no PCT; cycling for tolerance is reasonable
AAS-stacked peptide cycles need real PCT for the steroid component, not the peptides
Recombinant HGH may benefit from tapered cessation — discuss with prescriber
When in doubt, cycle (planned break) is almost always safe; PCT carries its own risks (estrogen rebound, etc.)

⚠️ What We Don't Know

Whether very-long-term GH-secretagogue use causes irreversible pituitary changes
Optimal cycle length for each secretagogue (8-12 weeks is convention, not RCT-validated)
Whether on/off cycling actually preserves long-term effectiveness vs continuous use
How peptide cycling interacts with TRT in men on long-term testosterone

FAQ

Frequently Asked Questions

Do I need PCT after BPC-157?

No. BPC-157 does not suppress the HPTA — it does not affect LH, FSH, testosterone, estrogen, or any reproductive hormone. Stopping BPC-157 does not require clomid, nolvadex, hCG, or any PCT protocol. The same applies to TB-500, GHK-Cu, MOTS-c, KPV, Selank, Semax, DSIP, and oxytocin.

Should I cycle ipamorelin and CJC-1295?

Yes — but to manage receptor desensitization, not HPTA suppression. The convention is 8-12 weeks on followed by 4-6 weeks off. The off-period allows pituitary GHRHR and GHSR receptors to resensitize so the secretagogues remain effective. This is "cycling" not "PCT" — no clomid, nolvadex, or hCG needed.

I ran BPC-157 alongside RAD-140 — do I need PCT?

Yes — for the RAD-140. SARMs suppress HPTA, sometimes substantially (RAD-140 at 10-20 mg can suppress testosterone >50%). Standard SARM PCT (typically 4-6 weeks of clomid 25-50 mg/day or nolvadex 20-40 mg/day) is appropriate. BPC-157 plays no role in the PCT decision — it is a passenger in this protocol.

Can I run sermorelin or tesamorelin year-round?

Possible but contraindicated for most users due to receptor desensitization. Continuous high-dose secretagogue use leads to diminishing returns. Most protocols suggest 8-12 weeks on / 4-6 weeks off. Some users run at lower maintenance doses indefinitely without breaks; data on long-term continuous low-dose use is limited.

What about recombinant HGH (Genotropin, Norditropin)?

Different category. Exogenous HGH provides direct negative feedback to the pituitary, mildly suppressing endogenous GH production. Discontinuation is typically a tapered approach over weeks rather than a PCT protocol. Symptoms during withdrawal can include fatigue, irritability, and depressed mood. Always coordinate with the prescribing physician.